186 related articles for article (PubMed ID: 17053822)
1. [Prevalence of anti hepatitis C antibodies in patients with chronic renal failure receiving conservative therapy].
de Los Ríos R; Bussalleu A; Hurtado A; Valdivia J; Huerta Mercado J; Battilana C; Pala M; Pinto JL; Piscoya A; Cedrón H
Rev Gastroenterol Peru; 2006; 26(3):265-70. PubMed ID: 17053822
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C viral in patients with terminal chronic kidney failure. I. Prevalence].
González-Michaca L; Mercado A; Gamba G
Rev Invest Clin; 2000; 52(3):246-54. PubMed ID: 10953607
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
6. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005.
Soto-Salgado M; Pérez CM; Burgos-Calderón R; Torres EA; Suárez E
P R Health Sci J; 2009 Mar; 28(1):18-23. PubMed ID: 19266735
[TBL] [Abstract][Full Text] [Related]
7. [Anti HCV in hemodialyzed patients: reduction of the prevalence and association with epidemiological variables].
Padrone M; Corallini O; Cocozzella D; Malca M; Borzi S; Barrio M; Adrover RE; Cuffini AM; Gomez C; Giamona AM; Brawlasky G; Newmann P; Dell Amo M; Fraquelli E; Curciarello JO
Acta Gastroenterol Latinoam; 1999; 29(3):91-4. PubMed ID: 10533653
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B and C viruses in pre-dialysis patients with chronic renal failure.
Salako BL; Ayodele OE; Kadiri S; Arije A
Afr J Med Med Sci; 2002 Dec; 31(4):311-4. PubMed ID: 15027769
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hepatitis C virus among long-term dialysis patients: a 9-year study in an Italian region.
Di Napoli A; Pezzotti P; Di Lallo D; Petrosillo N; Trivelloni C; Di Giulio S;
Am J Kidney Dis; 2006 Oct; 48(4):629-37. PubMed ID: 16997059
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen.
Selm SB
Saudi J Kidney Dis Transpl; 2010 Nov; 21(6):1165-8. PubMed ID: 21060200
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors for hepatitis C in hemodialysis and its impact on the waiting list for kidney transplantation].
Méndez Chacón P; Vidalón A; Vildosola H
Rev Gastroenterol Peru; 2005; 25(1):12-8. PubMed ID: 15818418
[TBL] [Abstract][Full Text] [Related]
12. [The prevalence of anti-hepatitis virus C antibodies in chronic hemodialysis patients].
Camps DH; Azcona S; Bertola S; Kohn I; Noguera E; Garzón Maceda F; Bongiorno E; Massari P; De Arteaga J
Medicina (B Aires); 1992; 52(6):511-5. PubMed ID: 1340899
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus infection and the dialysis patient.
Fabrizi F; Lunghi G; Ganeshan SV; Martin P; Messa P
Semin Dial; 2007; 20(5):416-22. PubMed ID: 17897248
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
Resić H; Sahović V; Mesić E; Leto E
Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of hepatitis C virus antibodies among different populations of relative and attributable risk.
Daw MA; Elkaber MA; Drah AM; Werfalli MM; Mihat AA; Siala IM
Saudi Med J; 2002 Nov; 23(11):1356-60. PubMed ID: 12506296
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and epidemiology of hepatitis C infection in patients on peritoneal dialysis in France. French PD centers.
Durand PY; Chanliau J; Gamberoni J; Hestin D; Kessler M
Adv Perit Dial; 1996; 12():167-70. PubMed ID: 8865894
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and seroconversion to HCV in hemodialyzed patients, and epidemiological factors.
Morales MF; Lossi JS; Alderete TN; Noli D
Transplant Proc; 1996 Dec; 28(6):3402-5. PubMed ID: 8962329
[No Abstract] [Full Text] [Related]
19. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center.
Khattab OS
Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):110-5. PubMed ID: 18087139
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus infection in 2,744 hemodialysis patients followed regularly at nine centers in Hiroshima during November 1999 through February 2003.
Kumagai J; Komiya Y; Tanaka J; Katayama K; Tatsukawa Y; Yorioka N; Miyakawa Y; Yoshizawa H
J Med Virol; 2005 Aug; 76(4):498-502. PubMed ID: 15977246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
